{"id":"https://openalex.org/W2596954440","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7516","title":"Three-arm randomized phase II study of carboplatin (C) and paclitaxel (P) in combination with cetuximab (CET), IMC-A12, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508).","display_name":"Three-arm randomized phase II study of carboplatin (C) and paclitaxel (P) in combination with cetuximab (CET), IMC-A12, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508).","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2596954440","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7516","mag":"2596954440"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.7516","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7516","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.7516","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074428655","display_name":"Nasser H. Hanna","orcid":"https://orcid.org/0000-0002-7046-6426","observed_orcids":["https://orcid.org/0000-0002-7046-6426"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nasser H. Hanna","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018666301","display_name":"Suzanne Eleanor Dahlberg","orcid":"https://orcid.org/0000-0001-5139-831X","observed_orcids":["https://orcid.org/0000-0001-5139-831X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suzanne Eleanor Dahlberg","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016348831","display_name":"Jill Kolesar","orcid":"https://orcid.org/0000-0003-1802-6439","observed_orcids":["https://orcid.org/0000-0003-1802-6439","https://orcid.org/0000-0001-8575-4546"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jill Kolesar","raw_affiliation_strings":["University of Wisconsin Carbone Cancer Center, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Wisconsin Carbone Cancer Center, Madison, WI","institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071851332","display_name":"Fred R. Hirsch","orcid":"https://orcid.org/0000-0002-6885-1894","observed_orcids":["https://orcid.org/0000-0002-6885-1894"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fred R. Hirsch","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088178599","display_name":"Suresh S. Ramalingam","orcid":"https://orcid.org/0000-0002-0757-3106","observed_orcids":["https://orcid.org/0000-0002-0757-3106"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suresh S. Ramalingam","raw_affiliation_strings":["Winship Cancer Institute, Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute, Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050185260","display_name":"Joan H. Schiller","orcid":"https://orcid.org/0000-0003-0990-1211","observed_orcids":["https://orcid.org/0000-0003-0990-1211"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan H. Schiller","raw_affiliation_strings":["University of Texas Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"7516","last_page":"7516"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.8270000219345093},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.781000018119812},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8209999799728394},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.4779999852180481},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.765999972820282},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.4300000071525574},{"id":"https://openalex.org/keywords/early-trial-termination","display_name":"early trial termination","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9359634518623352},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6805540323257446},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5833264589309692},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.57581627368927},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5392974019050598},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.49982428550720215},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.4763772189617157},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.453977108001709},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4330306053161621},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4292660355567932},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3984624445438385},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37634286284446716},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.373543918132782},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3606838881969452},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.11591055989265442},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.10602462291717529},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.7516","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.7516","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.7516","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2128649135","https://openalex.org/W2562983943","https://openalex.org/W2321399249","https://openalex.org/W2245550468","https://openalex.org/W2244058194","https://openalex.org/W2275177970","https://openalex.org/W2607358647","https://openalex.org/W2769988386","https://openalex.org/W2011573715","https://openalex.org/W3080436544"],"abstract_inverted_index":{"7516":[0],"Background:":[1],"Pre-clinical":[2],"evidence":[3],"supports":[4],"the":[5,11,18,290],"clinical":[6],"investigation":[7,292],"of":[8,111,222,279,293],"inhibitors":[9],"to":[10,67,115,145,200],"insulin-like":[12],"growth":[13,20],"factor":[14,21],"receptor":[15,22],"(IGFR)":[16],"and":[17,25,132,140,256,264,267,270,281],"epidermal":[19],"(EGFR)":[23],"alone":[24,299],"in":[26,31,150,301,305],"combination":[27,302],"with":[28,34,53,85,104,303,307],"one":[29],"another":[30],"patients":[32,139,210],"(pts)":[33],"NSCLC.":[35],"Methods:":[36],"Pts":[37,52,64],"w/":[38],"chemotherapy-na\u00efve,":[39],"advanced":[40,308],"NSCLC,":[41],"not":[42,288,310],"eligible":[43,138,205,311],"for":[44,153,171,258,312],"bevacizumab-based":[45],"therapy,":[46],"ECOG":[47],"PS":[48,186],"0/1":[49],"were":[50,62,65,113,178,207,261],"eligible.":[51],"uncontrolled":[54],"or":[55,99,160,300],"untreated":[56],"brain":[57],"mets":[58],"and/or":[59],"severe":[60],"hyperglycemia":[61,241],"ineligible.":[63],"randomized":[66],"receive:":[68],"C":[69,159,294],"AUC":[70],"6":[71],"iv":[72,77,88,93],"+":[73,295,297],"P":[74],"200":[75],"mg/m2":[76],"on":[78,117],"day":[79],"1":[80],"every":[81,94],"3":[82],"wks":[83,96],"combined":[84],"either":[86,154],"CET":[87,304],"weekly":[89],"(arm":[90,97,101,156],"A),":[91],"IMC-A12":[92,298],"2":[95],"B),":[98],"both":[100],"C).":[102],"Patients":[103],"non-progressive":[105],"disease":[106],"(PD)":[107],"after":[108,203],"12":[109],"weeks":[110],"therapy":[112,120],"permitted":[114],"continue":[116],"maintenance":[118],"antibody":[119],"until":[121],"PD.":[122],"The":[123,134,194,252],"primary":[124],"objective":[125],"was":[126,182,196],"PFS.":[127],"Secondary":[128],"objectives":[129],"included":[130],"OS":[131,257],"toxicity.":[133],"design":[135],"required":[136],"180":[137],"had":[141],"an":[142],"88%":[143],"power":[144],"detect":[146],"a":[147],"60%":[148],"increase":[149],"median":[151,180,254],"PFS":[152,255],"comparison":[155],"A":[157,173],"vs":[158,163],"arm":[161],"B":[162],"C)":[164],"(1-sided":[165],"0.10":[166],"level":[167],"test).":[168],"Results:":[169],"Characteristics":[170],"arms":[172,259],"(n=39)/B":[174],"(n=42)/C":[175],"(n=48):":[176],"males":[177],"51%/57%/54%;":[179],"age":[181],"60,":[183],"62,":[184],"60;":[185],"0":[187],"49%/52%/60%;":[188],"stage":[189],"IV":[190],"87%/83%/94%;":[191],"adenocarcinoma":[192],"44%/26%/42%.":[193],"study":[195,286],"closed":[197],"prematurely":[198],"due":[199],"safety":[201],"concerns":[202],"129":[204],"pts":[206,306],"treated.":[208],"13":[209],"died":[211],"during":[212],"treatment":[213],"(A=6;":[214],"B=2;":[215],"C=5),":[216],"including":[217],"9":[218],"w/in":[219],"~1":[220],"mo":[221],"starting":[223],"therapy.":[224],"G3-5":[225],"toxicities,":[226],"all":[227],"attributions,":[228],"A/B/C:":[229],"anemia":[230],"16%/7%/13%;":[231],"neutropenia":[232,235],"27%/29%/42%;":[233],"febrile":[234],"7%/5%/4%;":[236],"thrombocytopenia":[237],"7%/10%/13%;":[238],"pneumonia":[239],"9%/2%/6%;":[240],"2%/10%/15%;":[242],"rash":[243],"5%/2%/8%;":[244],"hyponatremia":[245],"2%/5%/17%;":[246],"thromboembolic":[247],"events":[248],"2%/10%/0%;":[249],"fatigue":[250],"16%;22%/13%.":[251],"estimated":[253],"A/B/C":[260],"3.4,":[262],"4.3,":[263],"4.1":[265],"mos":[266],"11.7,":[268],"8.6,":[269],"8.4":[271],"mos,":[272],"respectively.":[273],"Conclusions:":[274],"Based":[275],"upon":[276],"apparent":[277],"lack":[278],"efficacy":[280],"excessive":[282],"premature":[283],"deaths,":[284],"this":[285],"does":[287],"support":[289],"continued":[291],"T":[296],"NSCLC":[309],"bevacizumab.":[313]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-03-23T00:00:00"}